Edwards Lifesciences Corporation (EW) — AI Analysis & Mentions

Over the past 20 years, Edwards Lifesciences has significantly outperformed the market, producing consistent annual returns exceeding 17%. With a market cap of $50.38 billion, it remains a solid pick for long-term investors focused on healthcare innovation.

With an annualized return of 17.21% over the last two decades, Edwards Lifesciences continues to be a solid choice in the healthcare sector. Investors should consider its long-term track record of outperformance against market benchmarks.